Dr. David Stojdl

One of Ottawa’s most-lauded biotech startups is strengthening its leadership team with several veteran pharmaceutical executives as the company enters “a new phase” of business growth.
An Ottawa biotech startup has received a US$41-million injection of venture capital to further develop its groundbreaking treatments that use the body’s own immune system to battle cancer.